#454: Bridging the Gap: Avoiding the MedTech Valley of Death with Dr. Adam Saltman

Global Medical Device Podcast · 6 Apr 2026 · 39m · Episode 454

AI in practice: 2 real uses of AI described

What this episode covers

Dr. Adam Saltman, Chief Medical Officer at NAMSA, explains why medical device startups fail in the 'valley of death' by building technology without validating unmet clinical needs, often getting stuck in a 'tech echo chamber.' He warns against the '510(k) trap,' where choosing the fastest regulatory pathway leads to commodity pricing and reimbursement hurdles because the device lacks distinct clinical evidence. Saltman also discusses the risks of 'automation bias' in AI, citing an X-ray failure where algorithms predicted mortality based on patient location rather than clinical data, emphasizing that AI must be treated as an assistant, not a replacement.

AI in practice

Where this conversation describes AI being used to build or deliver a product. Part of the AI in practice tracker.

Engineering & simulation

The speaker uses AI to draft an FDA breakthrough designation application by uploading guidance documents and technical files, then iteratively corrects the output to ensure accuracy before client submission.

“I'll pull the guidance document from FDA. I'll pull their technical files. I'll put it into my AI. I'll say, please draft an application. The application comes back to me. Of course, I read it. … I go back to the AI and I said, wait a minute, this part's wrong.”

Dr. Adam Saltman · Hear it at 17:57

Running the company

The speaker uses AI to summarize FDA guidance documents by uploading them to the tool, allowing for quick summaries despite the process remaining largely manual.

“I'm using a little bit of AI help in the sense that I can very quickly either point the AI to the website, they can look at it or I just download it and then upload it to the AI and say, give me a summary.”

Dr. Adam Saltman · Hear it at 9:49

Mentioned

Companies
NAMSA, FDA, Greenlight Guru, LSI, CMS
Tools
Zotero
Also
Claude, Medtech Innovator

Other shows on the same ground, closest first.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

  • Being an Engineer · 46m

    S5E8 Aaron Call | How to Find Money for MedTech Startups

    Aaron Call, founding principal of Jaunt, explains how his company helps MedTech startups navigate market intelligence and fundraising by focusing on customer discovery rather than just technical feasibility. He distinguishes between sustaining and disruptive innovation, detailing how Jaunt uses qualitative and quantitative research to validate product-market fit for Class I and II devices. Call also outlines the current venture capital landscape, noting the shift toward funding only exceptional companies, and discusses the integration of AI in healthcare administration and device development.

  • The Builder Circle · 1h 11m

    S2 E2: Demystifying Medical Device and System Development with Alan Cohen

    Alan Cohen, author of 'Prototype to Product' and a systems engineering manager specializing in radiation therapy devices, explains the complexities of medical device development to host Sera Evcimen. Cohen emphasizes that successful startups often emerge from collaborations between engineers and clinicians, and he details the critical importance of understanding reimbursement models, specifically CPT codes, before building a product. He advocates for using Fault Tree Analysis over FMEA for complex systems to manage risk efficiently and advises founders to balance lean documentation with rigorous process adherence to satisfy FDA requirements without over-engineering.

  • Being an Engineer · 51m

    S6E19 Stuart Grant | MedTech Innovation

    Dr. Stuart Grant, founder of Archetype MedTech, discusses his 25-year career at Johnson & Johnson and DePuy Synthes before launching his consultancy to help startups navigate medical device development. He details the challenges of securing funding, managing regulatory differences between the EU's MDR and the US FDA, and the strategic importance of narrow clinical indications. Grant also explores future trends in surgical robotics and AI, emphasizing the need for modular platforms and the value of accumulated engineering knowledge.

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.